2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Patient preferences for the treatment of paroxysmal nocturnal hemoglobinuria: interim results of a patient survey of ravulizumab (ALXN1210) and eculizumab. Abstract presented at Academy of Managed Care & Specialty Pharmacy Annual Meeting; San Diego, CA

      J Manag Care Specialty Pharm

      Read this article at

      ScienceOpen
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Comments

          Comment on this article